London, UK: A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, reported an intriguing discovery. The study, entitled “Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil”, was conducted by Dr. Samaira Younis and colleagues from the Danish Headache Center, Rigshospitalet Glostrup, University…
Dec. 16 2019 — The Crohn’s & Colitis Congress®, the premier conference for inflammatory bowel diseases (IBD) health care providers and researchers, invites media to register for the 2020 meeting. A partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA), the Congress will disseminate the latest research and care strategies to…
PHILADELPHIA, PA – Lung cancer is the leading cause of cancer death in the United States and approximately 75-80% of all cases are non-small cell lung cancer (NSCLC). Of these, 30-40% are considered locally advanced and are categorized as either Stage IIIA or IIIB. The currently accepted standard of care for patients with locally-advanced NSCLC…
DENVER/December 16, 2019 – Latex exposure could be detrimental to a horse’s respiratory health. That’s the surprising discovery from Morris Animal Foundation-funded research at the Royal Agricultural University and University of Nottingham. While further investigation is needed, researchers say latex could be among the allergens responsible for causing severe equine asthma (sEA), a serious horse…
COLUMBUS, Ohio – Scientists have developed a new gene-therapy technique by transforming human cells into mass producers of tiny nano-sized particles full of genetic material that has the potential to reverse disease processes. Though the research was intended as a proof of concept, the experimental therapy slowed tumor growth and prolonged survival in mice with…